A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction

JAMA

Volumn 276, Issue 11, 1996, Pages 882-888

  Stampfer, Meir J ^a,b,d   Krauss, Ronald M ^c   Ma, Jing ^a   Blanche, Patricia J ^c   Holl, Laura G ^c   Sacks, Frank M ^a,b   Hennekens, Charles H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HEART INFARCTION; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029741921     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.11.882     Document Type: Article

References (44)

1. Criqui MH, Heiss G, Cohn R. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med. 1993;328:1220-1225.
2. Manninen V, Tenkanea L, Koskinen P, et al, Joint effects of serum trigiyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation. 1992;85:37-45.
3. Brown MS, Goldstein JL. A receptor mediated pathway for cholesterol homeostasis. Science. 1986; 232:34-47.
4. Tyroler HA. Review of lipid-lowering clinical trials in relation to observational epidemiologic studies. Circulation. 1987;76:515-522.
5. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990; 323:1289-1298.
6. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982;23:97-104.
7. Austin MA, Breslow JL. Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
8. Austin MA, King M-C, Vranizan KM, Newman B, Krauss RM. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genrt. 1988;43:838-846.
9. Slyper AH. Low-density lipoprotein density and atheroselerosis. JAMA 1994;272:305-308.
10. Tornvall P, Karpe F, Carison LA, Hamsten A. Relationships of low density lipoprotein subfraetions to angiographicaily defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis. 1991;90:67-80.
11. Crouse JR, Parks JS, Schey HM, Kahl FR. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res. 1985;26:566-574.
12. Schaefer EJ, McNamara JR, Genest JL, et al. LDL particle size, lipoproteins, and apolipoproteins in premature coronary artery disease (CAD): confounding effects of beta blockers. Circulation. 1987; 76(suppl IV):531.
13. Campos H, Genest JJ, Blijlevens E, et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12:187-189.
14. Coresh J, Kwiterovich PO Jr, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res. 1993; 34:1687-1697.
15. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991;325:373-381.
16. Stampfer MJ, Burning J, Willett WC, Rosner B, Eberlein K, Hennekens CH.The 2×2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians. Stat Med. 1985;4: 111-116.
17. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989;329:129-135.
18. World Health Organizatioa IHD Registers: Report of the Fifth Working Group. Copenhagen, Denmark: World Health Organization; 1971.
19. SAS Institute Inc. SAS User's Guide: Basics, 1982 Edition. Cary, NC: SAS Institute Inc; 1982.
20. SAS Institute Inc. SAS User's Guide: Statistics, 5th Edition. Cary, NC: SAS Institute Inc; 1985.
21. Storer BE, Wacholder S, Breslow NE. Maximum likelihood fitting of general risk models to stratified data Apple Stat 1983;32:172-181.
22. Fisher WR, Heterogeneity of plasma low density lipoprotein: manifestations of the physiologic phenomenon in man. Metabolism. 1983;32:283-291.
23. Krauss RM. The tangied web of coronary risk of coronary risk factors. Am J Med. 1991:90(suppl 2A):36S-41S.
24. Feingold KR, Grunfeld C, Pang M, Doerrier W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb. 1992;12:1496-1502.
25. de Graaf J, Hak-Lemmers HLM, Hectors MPC, Demaker PCM, Hendriks JCM, Stalenhoef AFH. Enhanced susceptilbility to intro, oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thrmb. 1991;11:298-306.
26. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subtractions of differing density and particle size. Atherosclerosis. 1992;93:189-199.
27. Austin MA, Krauss RM. LDL density and atherosclerosis. JAMA. 1995;273:115.
28. Austin MA, Newman B, Selby JV, Edwards K, Mayer EJ, Krauss RM. Genetics of LDL subclass phenotypes in women twins: concordance, heritability, and commingling analysis. Arterioscler Thromb. 1993;13:687-695,
29. Williams PT, Krauss RM, Wood PD, Lindgren FT, Uiotas C, Vranizan KM. Lipoprotein subfractions of runners and sedentary men. Metabolism. 1986;35:45-52.
30. Lamon-Fava S, Fisher EC, Nelson ME, et al. Effect of exercise and menstrual cycle status on plasma lipids, low density lipoprotein particle size. and apolipoproteins. J Clin Endocrinol Metab. 1989; 68:191-199.
31. SacksFM, Gerhard M, Walsh BW. Sex hormones, lipoproteins, and vascular reactivity. Curr Opin Lipidol. 1995;6:161-166.
32. Austin MA. plasma triglyceride and coronary artery disease. Arterioscler Thromb. 1991;112-13.
33. NIH Consensus Development Panel on Triglyeeride, High-Density Lipoprotein, and Coronary Heart Disease. Trigiyceride, high-density lipoprotein, and Coronary heart disease. JAMA. 1993;269: 505-510.
34. Hokanson JE, Austin MA. Triglyceride is a risk factor for coronary disease in in men and women: a meta-anliysis population-based prospective studies, Circulation 1993;88(suppl 2):I-510. Abstract.
35. Bainton D, Miller NE, Bolton CH, et al. Plasma triglyceride and high density lipoprotein cholesterol as predictors of isehaemic heart disease in British men. Br Heart J. 1992;68:60-66.
36. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease: the PROCAM experience. Am J Cardiol. 1992;70: 733-737.
37. Sharrett AR. Patsch W, Sorlie PD, et al, for the ARIC Investigators. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: the Atheroscierosis Risk in Communities (ARIC) study. Arteroscier Thromb. 1994; 14:1098-1104.
38. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60:473-485.
39. Drexel H, Amann FW, Beran J, et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation. 1994;90:2230-2235.
40. Yudkin JS. Report of a Meeting of Physicians and Scientists, University College Medical School: hypertriglyceridaemia and vascular risk: triglycerides and coagulation. Lancet. 1993;342:781-787.
41. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988; 37:1595-1607.
42. Castro GR, Fielding CJ. Effects of postprandial lipemla in plasma cholesterol metabolism. J Clin Innest. 1985;75:874-882.
43. Tall A, Sammett D, Granot E. Mechanisms of enhanced cholesteryl ester transfer from HDL to apolipoprotein B-containing iipoproteins during alimentary lipemia. J Clin Invest. 1986;77:1163-1172.
44. Georgopoulos A, Kafpnek SD, Raikhel I. Diabetic postprandial triglyceride-rich lipoproteins increase esterified cholesterol accumulation in THP-1 macrophages. Metabolism. 1994;43:1063-1072.